Related Experiment Video
Updated: Jun 21, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Tubulointerstitial nephritis and uveitis syndrome
Silvana Guerriero1, Antonio Vischi, Giovanni Giancipoli
1Dipartimento di Oftalmologia e Otorinolaringoiatria, Division of Ophthalmology, University of Bari, Bari, Italy.
Tubulointerstitial nephritis and uveitis syndrome (TINU) may be underdiagnosed. Prompt diagnosis and immunosuppressive therapy, like cyclosporine, can lead to full recovery of vision and kidney function.
Area of Science:
- Ophthalmology
- Nephrology
- Immunology
Background:
- Tubulointerstitial nephritis and uveitis syndrome (TINU) is a rare condition often presenting with ocular and renal inflammation.
- Early diagnosis and treatment are crucial for preventing long-term complications.
Observation:
- A 13-year-old female presented with photophobia, ocular pain, and decreased visual acuity.
- Physical examination revealed bilateral papilledema, indicating increased intracranial pressure, often associated with ocular and renal conditions.
- Renal biopsy confirmed interstitial nephritis, a key feature of TINU.
Findings:
- The patient was treated with immunosuppressive therapy, including cyclosporine (3 mg/kg/d).
- After one year, visual acuity improved to 20/20.
- Ocular examination and laboratory tests returned to normal, indicating successful treatment.
Implications:
- This case highlights the importance of considering TINU in young patients with unexplained ocular and renal symptoms.
- Aggressive immunosuppressive treatment can effectively manage TINU, leading to favorable visual and renal outcomes.
- Increased awareness and timely intervention are essential for improving the prognosis of TINU syndrome.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology

